Two non-invasive tests — MRI scans and the lung clearance index (LCI) — were more sensitive to early lung…
Articles by Steve Bryson, PhD
A woman and her daughter were diagnosed with chronic rhinosinusitis, an inflammatory condition of the sinuses and nasal passages, with…
One year of Trikafta treatment improved lung function, reduced abnormalities in lung structure, and halted disease progression among school-age…
Using a newly enhanced gene-editing technology called prime editing, researchers in the U.S. have efficiently corrected the most common mutation…
Arcturus Therapeutics plans to soon submit an application to the U.S. Food and Drug Administration (FDA) seeking permission…
Among young children with cystic fibrosis (CF), starting the approved oral therapy Orkambi (ivacaftor/lumacaftor) led to favorable changes…
Despite some similarities, the lung composition of microbes and their antimicrobial resistance profiles differed between people with bronchiectasis and…
Scientists at the Broad Institute of MIT and Harvard have created a gene editing technology that may be able to…
CF AMR Syndicate, a U.K. research support group, has awarded BioVersys up to £500,000 ($636,000) to develop small…
A single dose of 4D Molecular Therapeutics’ inhaled gene therapy candidate 4D-710 improved or stabilized lung function in adults…